Genetic Studies Yield Clues to Treatment-Related Side Effects in Children with Cancer

Researchers have identified genetic variations in children with brain cancer that increased their risk of rapid hearing loss after treatment....

FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer

The FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer. Source link

Conference Report: Pursuing Progress Against HIV-Related Cancers

At the recent annual Conference on Retroviruses and Opportunistic Infections, several NCI researchers and NCI-funded investigators presented important new findings...

Treatment Helps Preserve Fertility for Some Women with Breast Cancer

In a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing...

Smoking’s Disease Burden: Worse than Previously Thought?

According to a new study, smoking may be responsible for far more deaths each year than previously thought. Source link

DNA "Minicircles" Could Improve Cancer Detection, Study Suggests

Injecting customized DNA “rings” into tumor-bearing mice caused the tumor cells to release a biomarker that can be detected with...

Intensive Pre-Stem Cell Transplant Regimen May be Best for Younger Patients with AML, MDS

Results from a large phase III clinical trial suggest that a highly intensive preparatory regimen should be used for younger...

FDA Approves Panobinostat for Some Patients with Multiple Myeloma

The FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two...

FDA Approves First Immunotherapy Treatment for Lung Cancer

The FDA has approved nivolumab to treat patients with advanced non-small cell lung cancer that has progressed during or after...